English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/62306
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


In search of neuroprotective therapies based on the mechanisms of estrogens

AuthorsDoncarlos, Lydia L.; Azcoitia, I.; García-Segura, Luis M.
Issue Date2007
PublisherFuture Drugs
CitationExpert Review of Endocrinology and Metabolism 2: 387- 397 (2007)
AbstractAlthough estradiol is a neuroprotective factor, estrogen therapy in older women increases the risk of adverse cognitive outcomes and poses additional peripheral risks, requiring careful use of estrogenic compounds as treatments for neurodegenerative conditions or neural injury. Potential alternatives to estrogen therapy to promote neuroprotection might include treatment with molecules that are able to interact with estrogen receptors, with alternative mechanisms of action, or with molecules that induce local estradiol synthesis in the brain, or a combination of all. However, before considering the broad clinical applications, more basic research is required to clarify the mechamsms of action and potential risks of some of these estrogen-based treatments. © 2007 Future Drugs Ltd.
Identifiersdoi: 10.1586/17446651.2.3.387
issn: 1744-6651
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.